Ipca Laboratories informs about updates

27 Apr 2023 Evaluate

Ipca Laboratories has informed that the US FDA conducted the inspection of the Company’s formulations manufacturing unit situated at Piparia (Silvassa) from 18th April, 2023 to 26 April, 2023. At the conclusion of the inspection, the US FDA issued a Form 483 with 3 observations. The Company will submit its comprehensive response on these observations to the US FDA within the stipulated time and shall work closely with the agency to resolve these issues at the earliest. The Company takes the quality and compliance issues with utmost importance and remains committed to maintain the highest standards of quality and compliance across all its facilities.

The above information is a part of company’s filings submitted to BSE.

Ipca Laboratories Share Price

1336.40 8.75 (0.66%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.